Identification of and intervention at the critical window of metabolic development, and therefore prevention of epigenetic modification-induced changes, has the potential to impact not only offspring fat mass and baseline insulin sensitivity, but also the robustness of the offspring to future metabolic challenges, such as obesity, T2D or cardiovascular disorders (31, 77). The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.